Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Stock Holdings Lowered by Stock Yards Bank & Trust Co.

Stock Yards Bank & Trust Co. trimmed its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 9.0% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 14,392 shares of the pharmacy operator’s stock after selling 1,428 shares during the period. Stock Yards Bank & Trust Co.’s holdings in Walgreens Boots Alliance were worth $174,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in the business. Pineridge Advisors LLC bought a new stake in shares of Walgreens Boots Alliance during the 4th quarter worth $26,000. Quest Partners LLC acquired a new position in shares of Walgreens Boots Alliance in the 4th quarter valued at $30,000. 1832 Asset Management L.P. increased its stake in Walgreens Boots Alliance by 282.1% in the 4th quarter. 1832 Asset Management L.P. now owns 1,219 shares of the pharmacy operator’s stock worth $32,000 after purchasing an additional 900 shares in the last quarter. New Covenant Trust Company N.A. acquired a new stake in Walgreens Boots Alliance during the 1st quarter worth about $35,000. Finally, First Personal Financial Services lifted its stake in Walgreens Boots Alliance by 260.0% during the first quarter. First Personal Financial Services now owns 1,800 shares of the pharmacy operator’s stock valued at $39,000 after buying an additional 1,300 shares in the last quarter. Institutional investors and hedge funds own 58.59% of the company’s stock.

Walgreens Boots Alliance Trading Down 0.6 %

NASDAQ:WBA opened at $9.01 on Thursday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.31 and a current ratio of 0.65. The company has a market capitalization of $7.78 billion, a P/E ratio of -1.34, a P/E/G ratio of 1.02 and a beta of 0.70. The stock’s 50 day moving average price is $10.40 and its 200 day moving average price is $14.89. Walgreens Boots Alliance, Inc. has a 52 week low of $8.46 and a 52 week high of $27.05.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last released its quarterly earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share for the quarter, missing analysts’ consensus estimates of $0.68 by ($0.05). Walgreens Boots Alliance had a negative net margin of 3.99% and a positive return on equity of 12.63%. The business had revenue of $36.40 billion for the quarter, compared to the consensus estimate of $35.94 billion. During the same quarter in the prior year, the business posted $1.00 EPS. The firm’s revenue for the quarter was up 2.8% compared to the same quarter last year. On average, research analysts forecast that Walgreens Boots Alliance, Inc. will post 2.86 EPS for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, September 12th. Stockholders of record on Wednesday, August 21st were paid a dividend of $0.25 per share. The ex-dividend date was Wednesday, August 21st. This represents a $1.00 annualized dividend and a dividend yield of 11.10%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently -14.84%.

Analyst Ratings Changes

Several research analysts have recently weighed in on the stock. Morgan Stanley dropped their target price on shares of Walgreens Boots Alliance from $13.00 to $9.00 and set an “underweight” rating on the stock in a research report on Friday, June 28th. UBS Group cut their target price on shares of Walgreens Boots Alliance from $17.00 to $12.00 and set a “neutral” rating on the stock in a research note on Wednesday, July 3rd. Bank of America decreased their target price on Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating for the company in a research report on Wednesday, September 4th. JPMorgan Chase & Co. dropped their price target on Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating on the stock in a research report on Friday, August 30th. Finally, Truist Financial decreased their price objective on Walgreens Boots Alliance from $20.00 to $13.00 and set a “hold” rating for the company in a research report on Friday, June 28th. Four research analysts have rated the stock with a sell rating, ten have given a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $14.73.

Check Out Our Latest Stock Analysis on Walgreens Boots Alliance

Walgreens Boots Alliance Company Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

See Also

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.